SELLAS Life Sciences Group, Inc.
SLS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001390478
No open-market purchases or sales by SELLAS Life Sciences Group, Inc. insiders were filed in the last 90 days; 193 institutions reported holding it in 13F filings for Q2 2026, worth $1.08B in total; no superinvestor holds it.
Q4 2023 vs. Q3 2023
How the institutions holding SELLAS Life Sciences Group, Inc. changed between Q3 2023 and Q4 2023.
All holders in Q4 2023All holders in Q3 2023
| Measure | Q3 2023 | Q4 2023 | Change |
|---|---|---|---|
| Holders | 28 | 31 | +3 |
| Shares | 2.77M | 3.51M | +746.1K (+27.0%) |
| Value | $4.54M | $3.72M | −$814.5K (−17.9%) |
New holders (8)
Institutions that held SELLAS Life Sciences Group, Inc. at the end of Q4 2023 but not at the end of Q3 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Armistice Capital, LLC | 820,000 | $869.2K | 0.02% |
| Group One Trading, L.P. | 186,355 | $197.5K | 0.01% |
| Renaissance Technologies LLC | 50,400 | $53.0K | 0.00% |
| Engineers Gate Manager LP | 16,857 | $17.9K | 0.00% |
| Two Sigma Securities, LLC | 15,304 | $16.2K | 0.00% |
| Millennium Management LLC | 11,239 | $11.9K | 0.00% |
| Bank of America Corp | 42 | $44 | 0.00% |
| JJJ Advisors Inc. | 11 | $12 | 0.00% |
Sold out (5)
Institutions that held SELLAS Life Sciences Group, Inc. at the end of Q3 2023 and filed for Q4 2023 without it.
| Institution | Shares, Q3 2023 | Value, Q3 2023 |
|---|---|---|
| Alyeska Investment Group, L.P. | 640,011 | $1.05M |
| Susquehanna International Group, LLP | 70,446 | $115.5K |
| Prosperity Financial Group, Inc. | 24,800 | $40.7K |
| Jane Street Group, LLC | 11,032 | $18.1K |
| UBS Group AG | 26 | $43 |